What does Jade Biosciences, Inc. do?
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company…
What is Jade Biosciences, Inc.'s P/E and P/B ratio?
Jade Biosciences, Inc. has a P/E ratio of -7.8 and a P/B ratio of 2.16.
What is Jade Biosciences, Inc.'s debt-to-equity ratio?
Jade Biosciences, Inc. has a debt-to-equity ratio of 0.00.
How much does Jade Biosciences, Inc. owe compared with what it owns?
Jade Biosciences, Inc. owes $0.07 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Jade Biosciences, Inc.'s Positivity rank?
Jade Biosciences, Inc. is ranked #3,741 of 6,774 companies globally and #1,693 of 4,000 in United States on PositoAI, with a Positivity Score of 20,281.
Does Jade Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Jade Biosciences, Inc..
Where can I read the latest news about Jade Biosciences, Inc.?
Recent headlines about Jade Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Jade Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Jade Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.